FUJIFILM Diosynth Biotechnologies partners with Tonix Pharmaceuticals (NASDAQ:TNXP) +7% to provide
contract manufacturing and development services to support the
manufacturing of TNX-1800, Tonix’s COVID-19 vaccine candidate for
clinical trial supply.
In February, Tonix announced a strategic
collaboration with Southern Research to support the development of
TNX-1800 to protect against the new coronavirus disease, COVID-19, based
on Tonix’s proprietary horsepox vaccine platform.
https://seekingalpha.com/news/3578961-tonix-partners-fujifilm-diosynth-on-covidminus-19-vaccine
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.